Black Titan (BTTC) vs Liminatus Pharma (LIMN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Black Titan is the larger company by market cap ($6.6 million vs $4.8 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BTTC | LIMN |
|---|---|---|
| Share price | $0.485 | $3.57 |
| Market cap | $6.64M | $4.80M |
| 1-day change | -2.02% | -3.25% |
| EPS (TTM) | $-0.46 | $-23.50 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.05 | $141.50 |
| 52-week low | $0.342 | $3.29 |
| Distance from 52-week high | -95.17% | -97.48% |
| Average volume | 11.84M | 453.28K |
| Shares outstanding | 13.70M | 1.34M |
| Employees | — | 1 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Liminatus Pharma
LIMN stock →Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 1 employees
BTTC vs LIMN FAQ
Which is bigger, Black Titan or Liminatus Pharma?
Black Titan (BTTC) is larger, with a market capitalization of $6.64M compared with $4.80M for Liminatus Pharma (LIMN).
Are Black Titan and Liminatus Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.